Novartis AG Common Stock (NVS)

Cost of Revenue

$3.68B

Quarterly · Period ending: · USD

NVS logo

NVS Cost of Revenue

Latest reported$3.68B
NVS Quarterly Cost of Revenue ($0.00 → $3.68B)
High-resolution chart · PNG

NVS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
3,680,521,000
3,459,000,000
3,541,731,000
3,539,000,000
3,322,000,000
3,227,000,000
3,324,000,000
3,234,000,000
3,173,000,000
3,096,000,000
3,022,000,000
3,117,000,000
3,342,000,000
2,991,000,000
4,073,000,000
2,874,000,000
3,751,000,000
3,856,000,000
3,976,000,000
3,938,000,000
3,914,000,000
4,039,000,000
4,217,000,000
3,753,000,000
3,429,000,000
3,722,000,000
3,992,000,000
3,776,000,000
3,406,000,000
3,251,000,000
4,926,000,000
3,463,000,000
3,558,000,000
3,451,000,000
4,489,000,000
4,323,000,000
4,258,000,000
4,105,000,000
4,489,000,000
4,368,000,000
4,451,000,000
4,212,000,000
4,549,000,000
4,388,000,000
4,487,000,000
3,980,000,000
4,416,000,000
4,421,000,000
4,378,000,000
4,130,000,000
5,312,000,000
4,126,000,000
4,087,000,000
4,606,000,000
5,087,000,000
4,575,000,000
4,610,000,000
4,484,000,000
5,118,000,000
4,788,000,000
4,619,000,000
4,458,000,000
4,524,000,000
3,662,000,000
3,206,000,000
3,096,000,000
3,667,000,000
3,103,000,000
2,824,000,000
2,808,000,000
2,834,000,000
3,021,000,000
2,936,000,000
2,648,000,000
3,013,000,000
3,034,000,000
2,497,000,000
2,488,000,000
2,514,000,000
2,529,000,000
2,225,000,000
2,182,000,000
2,517,000,000
2,450,000,000
1,975,000,000
1,853,000,000
1,882,000,000
1,613,000,000
1,594,000,000
1,536,000,000
1,608,000,000
1,500,000,000
1,423,000,000
1,363,000,000
1,760,000,000
1,211,000,000
1,297,000,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.